Share
Journal Information
Issue
Vol. 59. Issue 9.Pages 521-572 (November 2012)
Editorial
Lorcaserin approval in the United States: Paving the way?
Sue D. Pedersen, Arne Astrup
Endocrinol Nutr. 2012;59:521-2
Full text access
Original articles
Glucagon receptor is required for long-term survival: A natural history study of the Mahvash disease in a murine model
Run Yu, Song-Guang Ren, James Mirocha
Endocrinol Nutr. 2012;59:523-30
Full text access
Hyperuricemia and metabolic syndrome in children with overweight and obesity
Soralla Civantos Modino, M. Guadalupe Guijarro de Armas, Susana Monereo Mejías, July M. Montaño Martínez, Paloma Iglesias Bolaños, María Merino Viveros, Jose María Ladero Quesada
Endocrinol Nutr. 2012;59:533-8
Full text access
Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: The DIAbetes tipo 1 in Castilla La Mancha study
Julia Sastre, Pedro José Pinés, Jesús Moreno, Miguel Aguirre, Benito Blanco, Dulce Calderón, Sandra Herranz, Carlos Roa, ... the study group DIACAM 1
Endocrinol Nutr. 2012;59:539-46
Full text access
Consensus document
Detection of thyroid dysfunction in pregnant women: Universal screening is justified
Lluís Vila, Inés Velasco, Stella González, Francisco Morales, Emilia Sánchez, José Maria Lailla, Txanton Martinez-Astorquiza, Manel Puig-Domingo
Endocrinol Nutr. 2012;59:547-60
Full text access
Review article
Glucagon-like peptide 1 and cardiac cell survival
Susana Ravassa, Amaia Zudaire, Javier Díez
Endocrinol Nutr. 2012;59:561-9
Full text access
Scientific letter
Management of intentional overdose of insulin glargine
Anil Kumar, Christopher E. Hayes, Scott J. Iwashyna, Rita Boustani, Laura Duncan, John J. Mickell, Gary Francis
Endocrinol Nutr. 2012;59:570-2
Full text access
Special content about COVID-19
- Gut microbiota and type 2 diabetes mellitus
- Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
- Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
- Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Publication History